![](/img/cover-not-exists.png)
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
Ziegler, Anette-Gabriele, Achenbach, Peter, Berner, Reinhard, Casteels, Kristina, Danne, Thomas, Gündert, Melanie, Hasford, Joerg, Hoffmann, Verena Sophia, Kordonouri, Olga, Lange, Karin, Elding LarssVolume:
9
Language:
english
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2018-028578
Date:
June, 2019
File:
PDF, 620 KB
english, 2019